Cargando…
Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345846/ https://www.ncbi.nlm.nih.gov/pubmed/36877766 http://dx.doi.org/10.1182/bloodadvances.2022009548 |
Sumario: |
---|